Huons Global Completes Phase 1 Clinical Trial of HU-045 for Glabellar Wrinkle Improvement
[Asia Economy Reporter Minji Lee] Huons Global announced on the 10th that the improvement effect on glabellar wrinkles was confirmed in the domestic Phase 1 clinical trial evaluating the safety of HU-045 injection for adults requiring improvement of severe glabellar wrinkles.
Hot Picks Today
Up to 600 Million Won for Semiconductors, 160 Million Won Bonus for Loss-Making Non-Memory… Samsung Electronics Labor and Management Reach Tentative Deal on Unprecedented Performance Compensation (Comprehensive)
- "Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- U.S. Stocks Up 1% on War Negotiation Hopes... Will Korea Recover Recent Losses? [Good Morning Market]
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company stated, "Based on the results of the Phase 1 study, we plan to apply to the Ministry of Food and Drug Safety for the next phase clinical trial," and added, "We expect to generate economic benefits through domestic approval."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
